Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “lung cancer”
Sponsor: National Cancer Institute (NCI)
Colorectal Neoplasms · Breast Neoplasms
United States
Sponsor: Yongsheng Wang
Lung Cancer (NSCLC) · EGFR Activating Mutation · HER2
Sponsor: National Cancer Institute (NCI)
Neoplasms · Solid Tumors · Prostate Cancer · Lung Cancer
United States
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
Argentina, Australia, Brazil, Canada, Chile +10 more
Sponsor: Pfizer
Carcinoma · Non-Small-Cell Lung · Lung Cancer (NSCLC) · Lung Neoplasms
United States, China, Israel, Puerto Rico, Taiwan
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Non-small Cell Lung Cancer · Locally Advanced Disease
France
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Non-Small Cell Lung Cancer · Immunotherapy · Neoadjuvant Therapy
Canada
- Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant MesotheliomaCompleted
Sponsor: University of Leicester
Mesothelioma, Malignant
United Kingdom
- Tucatinib Continuation StudyNot Yet Recruiting
Sponsor: Pfizer
HER2-positive Breast Cancer · Cervical Cancer · Biliary Tract Neoplasms · Urothelial Cancer
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Nonsmall Cell Lung Cancer
France
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Chronic Myeloid Leukemia (CML) · Pancreatic Ca · Colon/Rectal Ca · Multiple Myeloma
United States
Sponsor: NRG Oncology
Metastatic Lung Small Cell Carcinoma · Metastatic Malignant Neoplasm in the Brain · Recurrent Lung Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8
United States, Canada
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Lung Cancer · Metastasis
France
- Feasibility and Uptake of Low-Dose CT Lung Cancer Screening in KuwaitNot Yet Recruiting
Sponsor: Sulaiman Khadadah
Lung Cancer · Lung Neoplasms
Kuwait
- Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment DiscontinuationActive Not Recruiting
Sponsor: Massachusetts General Hospital
Melanoma · Non-small Cell Lung Cancer
United States
Sponsor: Beijing Tsinghua Chang Gung Hospital
Acute Lung Injury(ALI) · Liver Cirrhosis · ARDS, Human · MASLD
China
Sponsor: Pfizer
Non-Small-Cell Lung · Esophageal Cancer · Cutaneous Melanoma
United States, Puerto Rico, South Korea
- A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)Recruiting
Sponsor: Astellas Pharma Global Development, Inc.
Non-small Cell Lung Cancer (NSCLC) · Anaplastic Lymphoma Kinase (ALK) Positive
United States, France, Spain
Sponsor: Rush University Medical Center
Radiation Esophagitis · Locally Advanced Lung Carcinoma
United States
- A Study of Lung Cancer RiskRecruiting
Sponsor: Memorial Sloan Kettering Cancer Center
Lung Cancer
United States
Sponsor: Mirati Therapeutics Inc.
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Austria, Belgium +30 more
Sponsor: AbbVie
Non-Small Cell Lung Cancer
United States, Brazil, China, Israel, Japan +2 more
- Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot StudyNot Yet Recruiting
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Non-Small Cell Lung Cancer · Immunotherapy · Neoadjuvant Therapy · Thoracic Surgery
Canada
- Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)Active Not Recruiting
Sponsor: Mirati Therapeutics Inc.
Advanced Cancer · Metastatic Cancer · Malignant Neoplasm of Lung
United States, Brazil, Croatia, France, Greece +13 more
Sponsor: Pfizer
Melanoma · Glioma · Thyroid Cancer · Non-Small Cell Lung Cancer
United States, Australia, Brazil, Canada, China +2 more